Ashton Thomas Securities, LLC Moderna, Inc. Transaction History
Ashton Thomas Securities, LLC
- $515 Billion
- Q3 2024
A detailed history of Ashton Thomas Securities, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Ashton Thomas Securities, LLC holds 235 shares of MRNA stock, worth $12,581. This represents 0.0% of its overall portfolio holdings.
Number of Shares
235Holding current value
$12,581% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MRNA
# of Institutions
1,036Shares Held
242MCall Options Held
9.26MPut Options Held
12.1M-
Baillie Gifford & CO43.4MShares$2.33 Billion4.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.6MShares$2.12 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$1.37 Billion0.07% of portfolio
-
State Street Corp Boston, MA15MShares$804 Million0.08% of portfolio
-
Theleme Partners LLP London, X07.23MShares$387 Million42.67% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $20.9B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...